Miami, FL, United States of America

Balakrishna L Lokeshwar

This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignees: University of Miami, The State University of New York, Other. Active years: 1998-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Balakrishna L Lokeshwar. Retrieved from https://idiyas.com/inventor/balakrishna-l-lokeshwar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 143(Granted Patents)


Company Filing History:


Years Active: 1998-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Balakrishna L Lokeshwar: Innovator in Medical Treatments

Introduction

Balakrishna L Lokeshwar is a notable inventor based in Miami, FL, who has made significant contributions to the field of medical treatments. He holds a total of four patents, showcasing his innovative approach to addressing various health issues.

Latest Patents

Among his latest patents is a method for treating meibomian gland disease. This method involves treating patients with topical tetracycline or its derivatives, as well as oral administration of chemically modified tetracycline (CMT). Another significant patent is a method of inhibiting cancer growth, specifically targeting sarcomas such as Kaposi's sarcoma using 6-demethyl-6-deoxy-4-de(dimethylamino)tetracycline (CMT-3).

Career Highlights

Balakrishna has worked with prestigious institutions, including the University of Miami and the State University of New York. His work has focused on developing innovative treatments that address critical health challenges.

Collaborations

He has collaborated with notable colleagues such as Marie G Selzer and Lorne M Golub, contributing to advancements in medical research and treatment methodologies.

Conclusion

Balakrishna L Lokeshwar's contributions to medical innovation through his patents reflect his dedication to improving patient care and treatment options. His work continues to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…